Using multiplex immunofluorescence, Calagua and colleagues identified the genomic alterations associated with immunogenic (PD-L1 ≥5% and extensive TILs) and nonimmunogenic (PD-L1 negative and no TILs) tumor foci (115). The gene discussed is CD274; the disease is neoplasm.